Atlas Trials

A Trail of Second-line Chemotherapy Sequential NKG2D CAR-NK Cell Therapy for Pancreatic Cancer

Clinical trial NCT06503497 · UNKNOWN

Trial details

NCT number
NCT06503497
Sponsor
Zhejiang University
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Pancreatic Cancer Non-resectable
Start date
2024-07-09
Primary completion
2025-07-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.